Inhibikase Therapeutics Inc (IKT)
Capital Expenditure
-$452.02K
TTM · Period ending: · USD
IKT Capital Expenditure
Latest reported-$452.02Kperiod ending
Latest reported-$452.02Kperiod ending
IKT TTM CapEx ($0.00 → -$452.02K)
TTM CapEx
High-resolution chart · PNG
IKT capital expenditure history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Capital Expenditure (USD) |
|---|---|
| -452,023 | |
| -452,023 | |
| -452,023 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| -14,238 | |
| -14,238 | |
| -14,238 | |
| -214,404 | |
| -243,254 | |
| -243,257 | |
| -243,260 | |
| -43,096 | |
| -12 | |
| -9 | |
| -6 | |
| -4 | |
| -1 | |
| -1 | |
| -1 | |
| -1 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |